Charles Béar QC successfully represented the National Institute for Health and Clinical Excellence (NICE) in fending off a challenge from pharmaceutical manufacturer Bristol-Myers Squibb.  Mr Justice Blake held that NICE had not contravened the EU Transparency Directive nor acted unfairly in not disclosing its experts’ economic model to the manufacturer.

Charles Béar QC was instructed by Beachcroft LLP.